EA
INSY

Emerald Acquisition’s Insys Therapeutics, Inc. INSY Stock Holding History

Emerald Acquisition’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$276K Sell
23,404
-44,468
-66% -$676K ﹤0.01% 2618
2016
Q2 		$878K Buy
+67,872
New +$989K ﹤0.01% 2237

Other funds holding INSY

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FHAM
Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Emerald Acquisition's INSY Position: Q3 2016 in Review

Emerald Acquisition reduced its Insys Therapeutics, Inc. (INSY) stake by 66% in Q3 2016, selling an estimated $676K and leaving 23,404 shares worth $276K. The position accounts for ﹤0.01% of the portfolio, ranked #2618.

Emerald Acquisition first reported a position in INSY in Q2 2016 and has held it in 2 quarters since. The position peaked at $878K in Q2 2016. 138 funds tracked by Wall St. Rank hold INSY as of Q3 2016.

  • Emerald Acquisition held 23,404 shares of Insys Therapeutics, Inc. worth $276K as of Q3 2016.
  • Emerald Acquisition sold 44,468 Insys Therapeutics, Inc. shares in Q3 2016, an estimated $676K.
  • Insys Therapeutics, Inc. made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2618 holding.
  • Emerald Acquisition first reported a position in Insys Therapeutics, Inc. in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's Insys Therapeutics, Inc. position peaked at $878K in Q2 2016.
  • 138 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.